3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioma
4
Non-Muscle Invasive Bladder Neoplasms
3
Wilms Tumor
2
Urinary Bladder Neoplasms
2
Rhabdoid Tumor
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Multiple Myeloma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Interventions
Gemcitabine
6
Cisplatin
6
Oxaliplatin
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Fluorouracil
4
fludarabine
3
durvalumab
3
Taxes
3
pembrolizumab
2
futibatinib
2
Specimen Handling
2
Platinum
2
Paclitaxel
2
Nivolumab
2
Irinotecan
2
Folfox protocol
2
Fluorodeoxyglucose F18
2
Cyclophosphamide
2
Carboplatin
2
Biopsy
2
1,2-diaminocyclohexaneplatinum II citrate
2
zimberelimab
1
ulixertinib
1
tocilizumab
1
tivozanib
1
tislelizumab
1
regorafenib
1
pevonedistat
1
olutasidenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
erdafitinib
×
30 days
×
Clear all
No trials found.